We also detected downregulation of Tcea3 expression in dilated cardiomyopathy tissue from humans, indicating the potential clinical application of Tcea3 as an anti-myocardial remodeling agent, which, however, needs to be further confirmed. This evidence concerns the gene TCEA3 and dilated cardiomyopathy.